The Effects of Oral Isotretinoin in Women with Acne and Polycystic Ovary Syndrome

G Acmaz, L Cınar, B Acmaz, H Aksoy, Yusuf Taner Kafadar, Y Madendag, F Ozdemir, E Sahin, I Muderris, G Acmaz, L Cınar, B Acmaz, H Aksoy, Yusuf Taner Kafadar, Y Madendag, F Ozdemir, E Sahin, I Muderris

Abstract

Introduction: Many patients who were diagnosed as polycystic ovary syndrome- (PCOS-) related acne were not capable of sustaining or beginning oral contraceptive pills (OCPs) due to pill scaring, contraindications of OCP use, migraine, or smoking. In this situation, oral isotretinoin treatment may become an important option for PCOS-related acne. The aim of the study was to determine the effects of isotretinoin treatment on PCOS patients who were complicated with severe cystic acne.

Materials and methods: This study consisted of 40 female patients diagnosed as PCOS complicated with severe cystic acne. These patients were not eligible candidates for OCP use due to migraine, thrombophilia, heavy smoking, or pill scare. To establish baseline values of hormone levels, on days 2-5 of the menstrual cycle, venous blood samples were obtained. Moreover Modified Ferriman-Gallwey (mFG) score, acne score (AS), follicle count, and bilateral ovarian volumes were evaluated both before and after isotretinoin treatment.

Results: Isotretinoin treatment significantly decreased Ferriman-Gallwey score, free testosterone, insulin level, hemoglobin level, acne score, and ovarian volume. Increased triglyceride and cholesterol levels were detected after treatment.

Conclusion: Isotretinoin treatment may have beneficial effects on free testosterone, insulin, acne score, and Ferriman-Gallwey score. Solely isotretinoin administration may supply adequate healing in PCOS patients' symptoms complicated with severe cystic acne who is not eligible candidates for OCP use. This trial is registered with Clinicaltrials.gov NCT02855138.

References

    1. Sharif E., Rahman S., Zia Y., Rizk N. M. The frequency of polycystic ovary syndrome in young reproductive females in Qatar. International Journal of Women's Health. 2017;9:1–10. doi: 10.2147/IJWH.S120027.
    1. Boztosun A., Açmaz G., Ozturk A., Müderris I. I. Clinical efficacy of low dose flutamide plus diane-35 in the treatment of idiopathic hirsutism and polycystic ovary syndrome. Ginekologia Polska. 2013;84(4):258–262.
    1. Seaman H. E., De Vries C. S., Farmer R. D. T. Differences in the use of combined oral contraceptives amongst women with and without acne. Human Reproduction. 2003;18(3):515–521. doi: 10.1093/humrep/deg090.
    1. Melnik B. The role of transcription factor FoxO1 in the pathogenesis of acne vulgaris and the mode of isotretinoin action. Giornale Italiano Di Dermatologia E Venereologia. 2010;145(5):559–571. doi: 10.1111/j.1365-2133.2010.09754.x.
    1. Nelson A. M., Cong Z., Gilliland K. L., Thiboutot D. M. TRAIL contributes to the apoptotic effect of 13-cis retinoic acid in human sebaceous gland cells. British Journal of Dermatology. 2011;165(3):526–533. doi: 10.1111/j.1365-2133.2011.10392.x.
    1. Melnik B. Apoptosis may explain the pharmacological mode of action and adverse effects of isotretinoin, including teratogenicity. Acta Dermato-Venereologica. 2017;97(2):173–181. doi: 10.2340/00015555-2535.
    1. Chen W., Obermayer-Pietsch B., Hong J.-B., et al. Acne-associated syndromes: models for better understanding of acne pathogenesis. Journal of the European Academy of Dermatology and Venereology. 2011;25(6):637–646. doi: 10.1111/j.1468-3083.2010.03937.x.
    1. Melnik B. C. Overexpression of p53 explains isotretinoin's teratogenicity. Experimental Dermatology. 2018;27(1):91–93. doi: 10.1111/exd.13420.
    1. Melnik B. C. p53: key conductor of all anti-acne therapies. Journal of Translational Medicine. 2017;15(1) doi: 10.1186/s12967-017-1297-2.
    1. Agamia N. F., Hussein O. M., Abdelmaksoud R. E., et al. Effect of oral isotretinoin on the nucleo-cytoplasmic distribution of FoxO1 and FoxO3 proteins in sebaceous glands of patients with acne vulgaris. Experimental Dermatology. 2018;27(12):1344–1351. doi: 10.1111/exd.13787.
    1. Shi G., Liao P.-Y., Cai X.-L., et al. FoxO1 enhances differentiation and apoptosis in human primary keratinocytes. Experimental Dermatology. 2018;27(11):1254–1260. doi: 10.1111/exd.13775.
    1. Fox L., Csongradi C., Aucamp M., du Plessis J., Gerber M. Treatment modalities for acne. Molecules. 2016;21(8):p. 1063. doi: 10.3390/molecules21081063.
    1. Acmaz G., Ata M., Gulhan A., Acmaz B., Ata F., Aksoy H. Evaluation of the macula, retinal nerve fiber layer, and choroid thickness in women with polycystic ovary syndrome using spectral-domain optical coherence tomography. Reproductive Sciences. 2014;21(8):1044–1049. doi: 10.1177/1933719114522523.
    1. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Human Reproduction. 2004;81(1):19–25. doi: 10.1093/humrep/deh098.
    1. Rosendahl M., Ernst E., Rasmussen P. E., Andersen C. Y. True ovarian volume is underestimated by two-dimensional transvaginal ultrasound measurement. Fertility and Sterility. 2010;93(3):995–998. doi: 10.1016/j.fertnstert.2008.10.055.
    1. Aksoy H., Cinar L., Acmaz G., et al. The effect of isotretinoin on ovarian reserve based on hormonal parameters, ovarian volume, and antral follicle count in women with acne. Gynecologic and Obstetric Investigation. 2015;79(2):78–82. doi: 10.1159/000371551.
    1. Mason H. D., Cwyfan-Hughes S. C., Heinrich G., Franks S., Holly J. M. P. Insulin-like growth factor (IGF) I and II, IGF-binding proteins, and IGF-binding protein proteases are produced by theca and stroma of normal and polycystic human ovaries. The Journal of Clinical Endocrinology & Metabolism. 1996;81(1):276–284.
    1. Melnik B. C., Schmitz G. Role of insulin, insulin‐like growth factor‐1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Experimental Dermatology. 2009;18(10):833–841. doi: 10.1111/j.1600-0625.2009.00924.x.
    1. Melnik B. C. Apoptosis may explain the pharmacological mode of action and adverse effects of isotretinoin, including teratogenicity. Acta Dermato-Venereologica. 2017;97(2):173–181. doi: 10.2340/00015555-2535.
    1. Fuxjager M. J., Schuppe E. R., Hoang J., et al. Expression of 5α-and 5β-reductase in spinal cord and muscle of birds with different courtship repertoires. Frontiers in zoology. 2016;13(25)
    1. Karlsson T., Vahlquist A., Kedishvili N., Törmä H. 13-cis-retinoic acid competitively inhibits 3α-hydroxysteroid oxidation by retinol dehydrogenase RoDH-4: a mechanism for its anti-androgenic effects in sebaceous glands? Biochemical and Biophysical Research Communications. 2003;303(1):273–278. doi: 10.1016/S0006-291X(03)00332-2.
    1. Gökalp H., Aksakal A. B. Comparison of the efficacy of isotretinoin, cyproterone acetate/ethynil estradiol and combination therapies on serum androgenic hormone levels in females with acne vulgaris. Türkderm —Deri Hastalıkları ve Frengi Arşivi. 2012;46(4):206–209.
    1. Karadag A. S., Ertugrul D. T., Tutal E., Akin K. O. Isotretinoin influences pituitary hormone levels in acne patients. Acta Dermato-Venereologica. 2011;91(1):31–34. doi: 10.2340/00015555-1013.
    1. Melnik B. C., Schmitz G. Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Experimental Dermatology. 2009;18(10):833–841. doi: 10.1111/j.1600-0625.2009.00924.x.
    1. Fan W., Yanase T., Morinaga H., et al. Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor. The Journal of Biological Chemistry. 2007;282(10):7329–7338. doi: 10.1074/jbc.M610447200.
    1. Alimirah F., Panchanathany R., Cheny J., Zhang X., Ho S.-M., Choubey D. Expression of androgen receptor is negatively regulated by p53. Neoplasia. 2007;9(12):1152–1159. doi: 10.1593/neo.07769.
    1. Boudou P., Soliman H., Chivot M., et al. Effect of oral isotretinoin treatment on skin androgen receptor levels in male acneic patients. The Journal of Clinical Endocrinology & Metabolism. 1995;80(4):1158–1161. doi: 10.1210/jcem.80.4.7714084.
    1. Fabbrocini G., Izzo R., Faggiano A., et al. Low glycaemic diet and metformin therapy: A new approach in male subjects with acne resistant to common treatments. Clinical and Experimental Dermatology. 2016;41(1):38–42. doi: 10.1111/ced.12673.
    1. Shafiee M. N., Malik D. A., Yunos R. I. M., et al. The effect of Metformin on endometrial tumor-regulatory genes and systemic metabolic parameters in polycystic ovarian syndrome--a proof-of-concept study. Gynecological Endocrinology. 2015;31(4):286–290. doi: 10.3109/09513590.2014.989982.
    1. Huang X.-F., Luu-The V. Modulation of the androgenic response by recombinant human 11-cis retinol dehydrogenase. The Journal of Steroid Biochemistry and Molecular Biology. 2001;77(2-3):129–133. doi: 10.1016/S0960-0760(01)00038-3.
    1. Ozer H., Boztosun A., Acmaz G., Atilgan R., Akkar O. B., Kosar M. I. The efficacy of bevacizumab, sorafenib, and retinoic acid on rat endometriosis model. Reproductive Sciences. 2013;20(1):26–32.
    1. Abali R., Yuksel M. A., Aktas C., et al. Decreased ovarian reserve in female Sprague-Dawley rats induced by isotretinoin (retinoic acid) exposure. Reproductive BioMedicine Online. 2013;27(2):184–191. doi: 10.1016/j.rbmo.2013.04.010.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅